Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Orthofix Medical Inc
Nieuws
Orthofix Medical Inc
OFIX
NAS
: OFIX
| ISIN: US68752M1080
30/04/2025
13,91 USD
(-1,56%)
(-1,56%)
30/04/2025
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Technische analyse
TA
Toon enkel gratis nieuws
13 september 2024 ·
OFIX Investors Have Opportunity to Lead Orthofix Medical Inc. Securities Fraud Lawsuit Filed by the Schall Law Firm
· Persbericht
13 september 2024 ·
Orthofix Medical Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - OFIX
· Persbericht
12 september 2024 ·
OFIX Investors Have Opportunity to Lead Orthofix Medical Inc. Securities Fraud Lawsuit
· Persbericht
12 september 2024 ·
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Orthofix
· Persbericht
10 september 2024 ·
Lost Money on Orthofix Medical Inc.(OFIX)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
· Persbericht
7 september 2024 ·
OFIX Investors Have Opportunity to Lead Orthofix Medical Inc. Securities Fraud Lawsuit
· Persbericht
6 september 2024 ·
Orthofix Medical Inc. Class Action: Levi & Korsinsky Reminds Orthofix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - OFIX
· Persbericht
6 september 2024 ·
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Orthofix
· Persbericht
3 september 2024 ·
Levi & Korsinsky Notifies Shareholders of Orthofix Medical Inc.(OFIX) of a Class Action Lawsuit and an Upcoming Deadline
· Persbericht
31 augustus 2024 ·
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Orthofix
· Persbericht
31 augustus 2024 ·
ORTHOFIX MEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Orthofix Medical, Inc. - OFIX
· Persbericht
2 december 2023 ·
Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
· Persbericht
8 november 2023 ·
ORTHOFIX SHAREHOLDER NOTICE: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options
· Persbericht
3 november 2023 ·
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Orthofix Medical Inc. - OFIX
· Persbericht
3 november 2023 ·
ORTHOFIX SHAREHOLDER ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options
· Persbericht
29 oktober 2023 ·
ORTHOFIX ONGOING INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options
· Persbericht
26 oktober 2023 ·
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Orthofix Medical Inc. - OFIX
· Persbericht
24 oktober 2023 ·
ORTHOFIX INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options
· Persbericht
19 oktober 2023 ·
ORTHOFIX INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Orthofix To Contact Him Directly To Discuss Their Options
· Persbericht
18 oktober 2023 ·
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Orthofix Medical Inc. - OFIX
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe